138 related articles for article (PubMed ID: 7841032)
1. Mutation of the p53 gene precedes aneuploid clonal divergence in colorectal carcinoma.
Carder PJ; Cripps KJ; Morris R; Collins S; White S; Bird CC; Wyllie AH
Br J Cancer; 1995 Feb; 71(2):215-8. PubMed ID: 7841032
[TBL] [Abstract][Full Text] [Related]
2. Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer.
Carder P; Wyllie AH; Purdie CA; Morris RG; White S; Piris J; Bird CC
Oncogene; 1993 May; 8(5):1397-401. PubMed ID: 8479757
[TBL] [Abstract][Full Text] [Related]
3. Alteration of p53 gene in ovarian carcinoma: clinicopathological correlation and prognostic significance.
Niwa K; Itoh M; Murase T; Morishita S; Itoh N; Mori H; Tamaya T
Br J Cancer; 1994 Dec; 70(6):1191-7. PubMed ID: 7981076
[TBL] [Abstract][Full Text] [Related]
4. A rapid and nonisotopic method for the screening and sequencing of p53 gene mutations in formalin-fixed, paraffin-embedded tumors.
Soong R; Iacopetta BJ
Mod Pathol; 1997 Mar; 10(3):252-8. PubMed ID: 9071734
[TBL] [Abstract][Full Text] [Related]
5. A novel p53 mutation hotspot at codon 132 (AAG-->AGG) in human renal cancer.
Dahiya R; Deng G; Selph C; Carroll P; Presti J
Biochem Mol Biol Int; 1998 Feb; 44(2):407-15. PubMed ID: 9530523
[TBL] [Abstract][Full Text] [Related]
6. DNA-ploidy in advanced gastric carcinoma is less heterogeneous than in early gastric cancer.
Osterheld MC; Caron L; Demierre M; Laurini R; Bosman FT
Cell Oncol; 2004; 26(1-2):21-9. PubMed ID: 15371654
[TBL] [Abstract][Full Text] [Related]
7. p53 mutations and DNA ploidy in colorectal adenocarcinomas.
Campomenosi P; Assereto P; Bogliolo M; Fronza G; Abbondandolo A; Capasso A; Bellomo PF; Monaco R; Rapallo A; Sciutto A; Orecchia R; Geido E; Giaretti W
Anal Cell Pathol; 1998; 17(1):1-12. PubMed ID: 9807634
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance in molecular detection of p53 mutation in serum of patients with colorectal carcinoma.
Ito T; Kaneko K; Makino R; Konishi K; Kurahashi T; Ito H; Katagiri A; Kushima M; Kusano M; Mitamura K; Imawari M
Oncol Rep; 2003; 10(6):1937-42. PubMed ID: 14534722
[TBL] [Abstract][Full Text] [Related]
9. Clonal analysis of colorectal tumors using K-ras and p53 gene mutations as markers.
Dix BR; Robbins PD; Spagnolo DV; Padovan GL; House AK; Iacopetta BJ
Diagn Mol Pathol; 1995 Dec; 4(4):261-5. PubMed ID: 8634782
[TBL] [Abstract][Full Text] [Related]
10. Detection of p53 mutations by single-strand conformation polymorphisms (SSCP) gel electrophoresis. A comparative study of radioactive and nonradioactive silver-stained SSCP analysis.
Bosari S; Marchetti A; Buttitta F; Graziani D; Borsani G; Loda M; Bevilacqua G; Coggi G
Diagn Mol Pathol; 1995 Dec; 4(4):249-55. PubMed ID: 8634780
[TBL] [Abstract][Full Text] [Related]
11. Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas.
Dix B; Robbins P; Carrello S; House A; Iacopetta B
Br J Cancer; 1994 Oct; 70(4):585-90. PubMed ID: 7917901
[TBL] [Abstract][Full Text] [Related]
12. Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis.
Chang F; Syrjänen S; Tervahauta A; Kurvinen K; Wang L; Syrjänen K
Br J Cancer; 1994 Aug; 70(2):346-51. PubMed ID: 8054284
[TBL] [Abstract][Full Text] [Related]
13. p53 gene mutations in human urothelial carcinomas: analysis by immunohistochemistry and single-strand conformation polymorphism.
Oyasu R; Nan L; Szumel RC; Kawamata H; Hirohashi S
Mod Pathol; 1995 Feb; 8(2):170-6. PubMed ID: 7777479
[TBL] [Abstract][Full Text] [Related]
14. p53 mutations in childhood thyroid tumours from Belarus and in thyroid tumours without radiation history.
Smida J; Zitzelsberger H; Kellerer AM; Lehmann L; Minkus G; Negele T; Spelsberg F; Hieber L; Demidchik EP; Lengfelder E; Bauchinger M
Int J Cancer; 1997 Dec; 73(6):802-7. PubMed ID: 9399655
[TBL] [Abstract][Full Text] [Related]
15. Multiparameter flow cytometry for simultaneous assessment of p53 protein expression and cellular DNA content in oral squamous cell carcinomas: evidence for the development of aneuploid clones from p53-deficient diploid progenitor cells.
Hemmer J; Polackova J
Int J Oncol; 2000 Nov; 17(5):933-7. PubMed ID: 11029495
[TBL] [Abstract][Full Text] [Related]
16. p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network.
Gumerlock PH; Chi SG; Shi XB; Voeller HJ; Jacobson JW; Gelmann EP; deVere White RW
J Natl Cancer Inst; 1997 Jan; 89(1):66-71. PubMed ID: 8978408
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of p53 mutational status in intramucosal carcinoma of the colorectum.
Yamada S; Ajioka Y; Watanabe H; Hashidate H; Takaku H; Kazama S; Yokoyama J; Nishikura K; Fujiwara T; Asakura H
Jpn J Cancer Res; 2001 Feb; 92(2):161-6. PubMed ID: 11223545
[TBL] [Abstract][Full Text] [Related]
18. p53 gene mutations in early colorectal carcinoma. De novo vs. adenoma-carcinoma sequence.
Hasegawa H; Ueda M; Furukawa K; Watanabe M; Teramoto T; Mukai M; Kitajima M
Int J Cancer; 1995 Feb; 64(1):47-51. PubMed ID: 7665248
[TBL] [Abstract][Full Text] [Related]
19. A study of stabilisation of p53 protein versus point mutation in colorectal carcinoma.
Cripps KJ; Purdie CA; Carder PJ; White S; Komine K; Bird CC; Wyllie AH
Oncogene; 1994 Sep; 9(9):2739-43. PubMed ID: 8058340
[TBL] [Abstract][Full Text] [Related]
20. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas.
Sugai T; Takahashi H; Habano W; Nakamura S; Sato K; Orii S; Suzuki K
J Pathol; 2003 Jun; 200(2):168-76. PubMed ID: 12754737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
